Dr. Deborah M. Stephens
Claim this profileHuntsman Cancer Institute/University of Utah
Area of expertise
Acute Lymphocytic Leukemia
Deborah M. Stephens has run 8 trials for Acute Lymphocytic Leukemia. Some of their research focus areas include:
Chronic Lymphocytic Leukemia
Deborah M. Stephens has run 7 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Huntsman Cancer Institute/University Of Utah
Huntsman Cancer Institute
Clinical Trials Deborah M. Stephens is currently running
Pneumonia Vaccines
for CLL
This phase II trial tests whether the pneumococcal pneumonia vaccine series (PCV20 and PPSV23) works to mount an effective immune response in patients with chronic lymphocytic leukemia. PCV20 and PPSV23 are both vaccines that protect against bacteria that cause pneumococcal disease. Giving these vaccinations as series may make a stronger immune response and prevent against pneumococcal infections in patients with chronic lymphocytic leukemia. This is a single-center trial, conducted at Huntsman Cancer Institute.
Recruiting
1 award
Phase 2
5 criteria
Glofitamab Combinations
for Richter's Transformation
This research is being done to evaluate Glofitamab by itself or in combination with Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab as possible treatments for Chronic Lymphocytic Leukemia (CLL) that has transformed into Richter's Transformation (RT). The names of the study drugs involved in this research study are: * Glofitamab (a T-cell bispecific humanized monoclonal antibody) * Obinutuzumab (a humanized glycoengineered type II anti-CD20 monoclonal antibody) * Polatuzumab vedotin (an antibody-drug conjugate) * Pirtobrutinib (a selective inhibitor of BTK) * Atezolizumab (a humanized immunoglobulin monoclonal antibody) * Tocilizumab (a recombinant, humanized, anti-human monoclonal antibody)
Recruiting
1 award
Phase 2
17 criteria
More about Deborah M. Stephens
Clinical Trial Related
7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Deborah M. Stephens has experience with
- Venetoclax
- Obinutuzumab
- Ibrutinib
- Lenalidomide
- Rituximab
- JCAR017 (lisocabtagene Maraleucel)
Breakdown of trials Deborah M. Stephens has run
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah M. Stephens specialize in?
Deborah M. Stephens focuses on Acute Lymphocytic Leukemia and Chronic Lymphocytic Leukemia. In particular, much of their work with Acute Lymphocytic Leukemia has involved CD5 positive patients, or patients who are CD19 positive.
Is Deborah M. Stephens currently recruiting for clinical trials?
Yes, Deborah M. Stephens is currently recruiting for 3 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Deborah M. Stephens has studied deeply?
Yes, Deborah M. Stephens has studied treatments such as Venetoclax, Obinutuzumab, Ibrutinib.
What is the best way to schedule an appointment with Deborah M. Stephens?
Apply for one of the trials that Deborah M. Stephens is conducting.
What is the office address of Deborah M. Stephens?
The office of Deborah M. Stephens is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.